Product Reports Resources Pricing Login Book a demo

Taxon Biosciences

Biotech & Life Sciences · Tiburon, United States · Founded 2000

Microbial structures for transformative apps in the agriculture, life sciences, and oil and gas industries MoreLess

Taxon Biosciences, founded in 2000 by microbial geneticists Matt Ashby and Jasper Rine, operated as a biotechnology firm specializing in microbial genomics. The company was established with the goal of creating a microbial genomics platform to address significant challenges in the agriculture, energy, and health science sectors. Based in Tiburon, California, Taxon Biosciences focused on utilizing proprietary advancements in genomics, bioinformatics, and microbiology. Its core business involved identifying, validating, and commercializing microbiome-based products derived from agricultural and environmental settings.

The company's primary service was to profile microbial communities using genomic tools to understand their structure and function. This involved conducting in-depth diversity profiles of selected sites to identify specific DNA sequences correlated with parameters of interest, such as the presence of certain gases or salinity levels. From this data, the firm developed quantitative assays for these indicator species, which could then be used in broader bioindicator surveys. The business catered to a range of markets, including the energy sector and clinical diagnostics. Its technology and extensive intellectual property portfolio in microbial consortia and genomics were geared towards developing new products like seed treatments, as well as foliar and soil applications for major row crops, fruits, and vegetables.

A significant milestone in the company's history was its acquisition by DuPont in April 2015 for an undisclosed sum. This acquisition was a strategic move by DuPont to enhance its in-house capabilities in biological solutions for the agriculture industry, complementing its existing seed and crop protection businesses. Prior to the acquisition, Taxon Biosciences had secured $4.01 million in a Series A funding round in April 2013, with investors including Formation 8, BP Ventures, and ConocoPhillips Technology Ventures. The integration into DuPont was intended to accelerate the discovery-to-market timeline for new biological products.

Keywords: microbial genomics, microbiome discovery, bioinformatics, crop biologicals, agricultural biotechnology, seed treatment, soil health, microbial consortia, genomics platform, environmental microbiology, bioindicator surveys, microbial diversity, industrial microbiome, agtech, biological solutions, crop protection, plant health, sustainable agriculture, DuPont acquisition, Matt Ashby, Jasper Rine

Company overview

Taxon Biosciences company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2000
Headquarters
Tiburon, United States
Employees
5
Open positions
None listed
Dealroom signal
55.1
client focusb2csub industryBioTechnologybusiness modelManufacturingsectorIntellectual PropertyindustryHealthsectorBiotechnologysectorOncologysectorDNAsectorCardiology and cardiovascularsectorGenetics and genomicssectorSpinoutsectorGenome EngineeringsectorOil & GassectorBiotech and Pharma

Valuation & funding

Taxon Biosciences funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Apr 2015 $0 DuPont
SERIES AEquity / VC Nov 2013 $9.1M $36M BP Ventures
SERIES AEquity / VC May 2013 $4M $16M BP Ventures · BP Global
SPINOUTOther financing Jan 2000 $0 University of California, Berkeley
Showing 4 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 5
2025 5
2024 1
2023 1
2022 1
2021 1
2020 1
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Taxon Biosciences website traffic

Latest recorded traffic for Taxon Biosciences is 210 monthly website visits. Taxon Biosciences's team grew 0% over the past year.

Latest monthly visits210 1-year team growth0%
Monthly website visits40 observations · Apr 2016–Jun 2024
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Taxon Biosciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Taxon Biosciences's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Taxon Biosciences's cap table

Sourced from Dealroom's funding and investor records.

Series A 2 investors entered at this stage
BP Global
BP Ventures
Other known 4 additional known investors
DuPont
University of California, Berkeley
Builders VC
Tanguy Chau

Global footprint

Where Taxon Biosciences has talent and traffic

Workforce by country
🇺🇸 United States · Tiburon HQ
Book a demo for the full country breakdown

In the news

Latest news about Taxon Biosciences

Recent press, funding announcements, and product moves mentioning Taxon Biosciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Taxon Biosciences

An AI-synthesized read of the highest-engagement posts about Taxon Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Taxon Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.